Pulse Biosciences, Inc.

PLSE · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$54-$42-$59-$64
Dep. & Amort.$1$1$1$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$14$7$5$15
Change in WC$2$1-$4-$6
Other Non-Cash$0$0$9$0
Operating Cash Flow-$36-$33-$47-$54
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$8
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0-$0-$0$8
Financing Activities
Debt Repay.$0$0$65$0
Stock Issued$60$16$15$57
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$50-$0$0$6
Financing Cash Flow$110$16$80$63
Forex Effect$0$0$0$0
Net Chg. in Cash$74-$17$33$16
Supplemental Information
Beg. Cash$44$61$29$12
End Cash$118$44$61$29
Free Cash Flow-$36-$33-$47-$55
Pulse Biosciences, Inc. (PLSE) Financial Statements & Key Stats | AlphaPilot